These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 11575817)
1. Is HCFA's reimbursement policy controlling quality of care for end-stage renal disease patients? Lockridge RS; McKinney JK ASAIO J; 2001; 47(5):466-8. PubMed ID: 11575817 [No Abstract] [Full Text] [Related]
2. The social contract and the treatment of permanent kidney failure. Rettig RA JAMA; 1996 Apr; 275(14):1123-6. PubMed ID: 8601933 [No Abstract] [Full Text] [Related]
3. From fee-for-service to capitation: factors driving ESRD reimbursement system change. Day LM Nephrol News Issues; 1997 Apr; 11(4):22-3, 31. PubMed ID: 9287685 [No Abstract] [Full Text] [Related]
4. Bundling, and what is important for patients. Eilers D; LeBeau K Nephrol News Issues; 2009 Dec; 23(13):11. PubMed ID: 20050433 [No Abstract] [Full Text] [Related]
5. End-stage renal disease, managed care, and capitation: implications for the renal community. Rubin RJ; Gaylin DS; Shapiro JR Adv Ren Replace Ther; 1997 Oct; 4(4):306-13. PubMed ID: 9356682 [No Abstract] [Full Text] [Related]
6. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. United States Renal Data System. Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S118-31. PubMed ID: 9713414 [No Abstract] [Full Text] [Related]
7. Will HCFA/CMS' new process and proposed criteria for making national coverage decisions help or hurt payment for DHD? Robers S ASAIO J; 2001; 47(5):464-5. PubMed ID: 11575816 [No Abstract] [Full Text] [Related]
8. Cost of daily hemodialysis. Robers S ASAIO J; 2001; 47(5):459-61. PubMed ID: 11575814 [No Abstract] [Full Text] [Related]
9. If daily dialysis is the answer, what is the question? Rettig RA Am J Kidney Dis; 2001 Apr; 37(4):862-5. PubMed ID: 11273889 [No Abstract] [Full Text] [Related]
10. Peritoneal Dialysis as the Dialysis Initial Modality of Choice for Renal Replacement Therapy Initiation: Moving from "Why" to "Why Not". Subramanian S; Javaid MM Blood Purif; 2017; 44(2):106-107. PubMed ID: 28448966 [No Abstract] [Full Text] [Related]
11. The 2011 ESRD prospective payment system: perspectives of a home dialysis patient advocate. Peckham B Am J Kidney Dis; 2011 Apr; 57(4):559-61. PubMed ID: 21333429 [No Abstract] [Full Text] [Related]
12. Policy and research in end-stage renal disease. Jones KR Image J Nurs Sch; 1987; 19(3):126-9. PubMed ID: 3117675 [No Abstract] [Full Text] [Related]
13. Rediscovering method II as a reimbursement option. Day LM Nephrol News Issues; 1998 Oct; 12(10):22-5. PubMed ID: 10196951 [TBL] [Abstract][Full Text] [Related]
15. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration. Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874 [No Abstract] [Full Text] [Related]
16. [Cost-effectiveness analysis of renal replacement therapies: how should we design research on these interventions in Brazil?]. Sancho LG; Dain S Cad Saude Publica; 2008 Jun; 24(6):1279-90. PubMed ID: 18545754 [TBL] [Abstract][Full Text] [Related]
17. The case for daily dialysis: its impact on costs and quality of life. Mohr PE; Neumann PJ; Franco SJ; Marainen J; Lockridge R; Ting G Am J Kidney Dis; 2001 Apr; 37(4):777-89. PubMed ID: 11273878 [TBL] [Abstract][Full Text] [Related]
18. Will the bundle improve the way care is delivered? Neumann ME Nephrol News Issues; 2010 Jan; 24(1):8. PubMed ID: 20196495 [No Abstract] [Full Text] [Related]
19. Excluded from universal coverage: ESRD patients not covered by Medicare. Thamer M; Ray NF; Richard C; Greer JW; Pearson BC; Cotter DJ Health Care Financ Rev; 1995; 17(2):123-46. PubMed ID: 10157372 [TBL] [Abstract][Full Text] [Related]